Reaction Details Report a problem with these data
Target
Histone acetyltransferase KAT2B [719-832]
Ligand
BDBM311509
Substrate
n/a
Meas. Tech.
PCAF AlphaLisa Binding Assay
IC50
56.0±n/a nM
Citation
 Albrecht, BK; Cote, A; Crawford, T; Duplessis, M; Good, AC; LeBlanc, Y; Magnuson, S; Nasveschuk, CG; Pastor, R; Romero, AF; Taylor, AM Therapeutic compounds and uses thereof US Patent  US10155764 Publication Date 12/18/2018 
Target
Name:
Histone acetyltransferase KAT2B [719-832]
Synonyms:
KAT2B | KAT2B_HUMAN | PCAF | PCAF (aa 719-832)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
13623.13
Organism:
Homo sapiens (Human)
Description:
Q92831[719-832]
Residue:
114
Sequence:
SKEPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNRYYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK
  
Inhibitor
Name:
BDBM311509
Synonyms:
CHEM-US-00229 | US10155764, Example 84
Type:
Small organic molecule
Emp. Form.:
C28H32N6O2
Mol. Mass.:
484.5927
SMILES:
C[C@H](Nc1nn(C)c(=O)c2cccnc12)[C@@H](N(C)C)c1ccc(cc1)C(=O)N(C)Cc1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: